USPTO serial 87783343
WEREWOLF THERAPEUTICS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEIN, JAMES W
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with WEREWOLF THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gwenn Roos
GWENN ROOS LAW OFFICE OF GWENN ROOS26 BROOKDALE AVENUEWELLESLEY, MA 02482UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research and development and consultation related thereto in the field of cancer and oncology; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of cancer and oncology; Research and development of vaccines and medicines; Research in the field of cancer and oncology; Research on the subject of pharmaceuticals; Research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Bacteriological research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Compiling data for research purposes in the field of medical science and medical consultancy; Laboratory research in the field of cancer and oncology; Laboratory research services relating to pharmaceuticals; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of cancer and oncology; Medical and scientific research information in the field of cancer and oncology; Pharmaceutical research and development; Pharmaceutical research services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and oncology; Technical research in the field of pharmaceutical studies; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 4, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 4, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 26, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 25, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 22, 2019 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Oct 22, 2019 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Oct 22, 2019 | PETG | PETITION TO REVIVE-GRANTED | — |
| Oct 22, 2019 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 7, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 7, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 4, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 3, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 2, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 2, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 9, 2019 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Apr 8, 2019 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Apr 8, 2019 | PETG | PETITION TO REVIVE-GRANTED | — |
| Apr 8, 2019 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Apr 8, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 8, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 4, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 4, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 10, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 10, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 20, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 17, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 17, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 17, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 17, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 17, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 17, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 7, 2018 | NWAP | NEW APPLICATION ENTERED | — |